Come up with a name for your new list and we'll add to it:
Innocoll raised a round of funding on July 26, 2012. Investors include
NewSmith Asset Management.
Innocoll is a global commercial stage specialty pharmaceutical company with late stage development programs targeting areas of significant unmet medical need. The company develops and manufactures a r…